Silvergate Pharmaceuticals
Greenwood Village, US · Delaware corporation · 1 known investors
Biotech
Founders & leadership
FS
Frank SegravePresident
MB
Michael BeckloffChief Development Officer
RM
Robert MauroChief Operating Officer
BC
Bhaskar ChaundhuriDirector
NE
Nathan EveryDirector
BB
Barry BarnardChief Financial Officer
MP
Mark ParrishDirector
PH
Patrick HeronDirector
Investors · 1
Reported raises · per SEC filings
Form D private placements▶$4.6MraisedOct 2016 · 10 investors · PharmaceuticalsRule 506(b)
▶$4.6MraisedOct 2016 · 10 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Bhaskar ChaundhuriDirector
- Barry BarnardExecutive Officer
- Laura MedinaExecutive Officer
- Frank SegraveExecutive Officer, Director
- Robert MauroExecutive Officer
- Mark ParrishDirector
- Patrick HeronDirector
- Nathan EveryDirector
- Michael BeckloffExecutive Officer
- Offering amount
- $4.6M
- Amount sold
- $4.6M
- First sale
- Oct 2016
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.6MraisedOct 2015 · 9 investors · PharmaceuticalsRule 506(b)
▶$1.6MraisedOct 2015 · 9 investors · Pharmaceuticals
Rule 506(b)Officers, directors & promoters on the filing
- Frank SegraveExecutive Officer, Director
- Michael BeckloffExecutive Officer
- Robert MauroExecutive Officer
- Patrick HeronDirector
- Bhaskar ChaundhuriDirector
- Nathan EveryDirector
- Barry BarnardExecutive Officer
- Mark ParrishDirector
- Offering amount
- $4.6M
- Amount sold
- $1.6M
- First sale
- Oct 2015
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.